Key result
IVC filters reduce subsequent PE risk ~50% but increase DVT risk.
Why the study?
Inferior vena cava filters are widely used to prevent pulmonary embolism, but uncertainty persists regarding their efficacy and safety.
Do inferior vena cava filters reduce the risk of pulmonary embolism in patients at risk of PE?
Population
Patients at risk of PE across 11 studies (6 RCTs and 5 prospective observational studies)
Comparison
IVC filters vs no filters
Design
Systematic review and meta-analysis of RCTs and prospective controlled observational studies
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The most striking news to come out of the research is how few papers exist. That to me speaks to the need for much more research in this area.”
“The most important message [of the current paper] lies... in the quantity and quality of the evidence that the authors were able to retrieve over an impressive time period spanning no less than 43 years.”
Supports selective short-term IVC filter use when anticoagulation is contraindicated; confirms PE-DVT trade-off without mortality benefit.
Meta-Analysis
Do inferior vena cava filters reduce the risk of pulmonary embolism in patients at risk of PE?
Odds Ratio: 0.5 (95% CI 0.33–0.75)
IVC filters reduce the risk of subsequent pulmonary embolism but increase the risk of deep vein thrombosis, without affecting overall mortality.
Bikdeli et al. (2017) conducted a meta-analysis in Risk of pulmonary embolism. Inferior vena cava (IVC) filters vs. None was evaluated on Subsequent pulmonary embolism (OR 0.50, 95% CI 0.33 to 0.75). Inferior vena cava filters reduced the risk of subsequent pulmonary embolism (OR 0.50; 95% CI 0.33-0.75) but increased the risk for deep vein thrombosis (OR 1.70; 95% CI 1.17-2.48).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: